Начало・Списък с акции・Zoetis Inc

Zoetis Inc

Затворен

СекторЗдравеопазване

75.98 -1.43

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

76.83

Максимум

79.78

Ключови измерители
By Trading Economics
Приходи	-2M 601M
Продажби	-125M 2.3B
P/E Средно за сектора	12.61 64.641
EPS	1.53
Дивидентна доходност	2.69
Марж на печалбата	26.569
Служители	14,500
EBITDA	-8M 939M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+28.58% upside

Дивиденти
By Acuity
Дивидентна доходност Средно за сектора	2.69% 2.31%
Следващи печалби	6.08.2026 г.
Следваща дата на дивидент	1.09.2026 г.
Следваща дата на екс-дивидент	30.10.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-16B 32B
Предишно отваряне	77.41
Предишно затваряне	75.98

Настроения в новините

By Acuity

43%

57%

135 / 340 Класиране в Healthcare

Zoetis Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

3.08.2026 г., 23:31 ч. UTC

Zoetis Inc shares are higher in after-market trading, continuing positive momentum after three consecutive sessions of gains amid favorable market sentiment.

1.08.2026 г., 00:01 ч. UTC

Zoetis Inc shares rose in after-market trading, recovering from an initial dip and reaching a high near the upper end of its one-month range.

31.07.2026 г., 23:06 ч. UTC

Zoetis Inc shares are higher in after-market trading, maintaining gains since Friday's close and remaining above the 20-day moving average.

30.07.2026 г., 19:03 ч. UTC

Zoetis Inc shares are lower, impacted by a decline in the Pharmaceuticals sub-sector. Earlier in the session, the stock peaked before falling.

29.07.2026 г., 22:51 ч. UTC

Zoetis Inc shares are trading lower in after-market hours. No specific news was identified to explain the decline amid broader market volatility.

28.07.2026 г., 23:02 ч. UTC

Zoetis Inc shares are higher in after-market trading, reflecting broader market strength amid investor optimism ahead of key earnings reports and the Federal Reserve meeting.

27.07.2026 г., 23:16 ч. UTC

News

Zoetis shares are lower in after-market hours following a class action lawsuit alleging securities fraud and reduced profit guidance to between $6.85 and $7.00 per share.

25.07.2026 г., 00:01 ч. UTC

Zoetis Inc. shares are trading higher in after-market hours, continuing a positive trend after closing higher for three consecutive sessions.

24.07.2026 г., 21:02 ч. UTC

Zoetis Inc shares are higher in after-market trading, rebounding from an initial dip despite a broader market decline influenced by disappointing earnings from Tesla and Alphabet.

23.07.2026 г., 20:02 ч. UTC

Zoetis Inc. shares are higher as strength in the pharmaceuticals sub-sector drives upward momentum, contributing to modest gains since Wednesday's close.

22.07.2026 г., 21:02 ч. UTC

Zoetis Inc. shares are lower in after-market trading, continuing a trend of five consecutive daily declines amid mixed market performance and rising crude oil prices.

21.07.2026 г., 17:51 ч. UTC

News

Zoetis Inc. shares are lower amid scrutiny from a securities fraud class action lawsuit alleging undisclosed market share declines and safety issues with Librela.

20.07.2026 г., 23:16 ч. UTC

Zoetis shares traded higher in after-market hours, maintaining stability above Monday's close despite broader market pressures from rising treasury yields.

Сравнение с други в отрасъла

Ценова промяна

Zoetis Inc Прогноза

Ценова цел

By TipRanks

28.58% нагоре

12-месечна прогноза

Среден 99.38 USD 28.58%

Висок 130 USD

Нисък 85 USD

Според 12 анализатори от Wall Street, предложили 12-месечна ценова цел за Zoetis Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

12 ratings

Купи

Задържане

Продай

Според 12 анализатори, дали борсови рейтинги на Zoetis Inc през последните 3 месеца.

Настроение

By Acuity

135 / 340 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Zoetis Inc

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.